Detalhe da pesquisa
1.
The lack of head-to-head randomised trials and the consequences for patients and national health service: The case of non-small cell lung cancer.
Eur J Clin Pharmacol
; 80(4): 519-527, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38244052
2.
Clinical Outcomes of Patients with Advanced Cancer and Pre-Existing Autoimmune Diseases Treated with Anti-Programmed Death-1 Immunotherapy: A Real-World Transverse Study.
Oncologist
; 24(6): e327-e337, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30796151
3.
Real-world outcomes of Italian patients with advanced non-squamous lung cancer treated with first-line pembrolizumab plus platinum-pemetrexed.
Eur J Cancer
; 202: 114006, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38489861
4.
Early prediction of resistance to tyrosine kinase inhibitors by plasma monitoring of EGFR mutations in NSCLC: a new algorithm for patient selection and personalized treatment.
Oncotarget
; 11(11): 982-991, 2020 Mar 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-32215186
5.
Evaluating the role of FAMIly history of cancer and diagnosis of multiple neoplasms in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: the multicenter FAMI-L1 study.
Oncoimmunology
; 9(1): 1710389, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32002308
6.
Listening understanding and acting (lung): focus on communicational issue in thoracic oncology.
Transl Cancer Res
; 8(Suppl 1): S16-S22, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-35117061
7.
Correlations Between the Immune-related Adverse Events Spectrum and Efficacy of Anti-PD1 Immunotherapy in NSCLC Patients.
Clin Lung Cancer
; 20(4): 237-247.e1, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30885550
8.
A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable.
J Immunother Cancer
; 7(1): 57, 2019 02 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-30813970
9.
Early Prediction of Response to Tyrosine Kinase Inhibitors by Quantification of EGFR Mutations in Plasma of NSCLC Patients.
J Thorac Oncol
; 10(10): 1437-43, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26295376